Development Level

Tbio 25 | 10,625
Tchem 13 | 1,890
Tdark 6 | 7,003

IMPC Term

embryonic lethality prior to o... 7 | 148
embryonic lethality prior to t... 7 | 187
preweaning lethality, complete... 5 | 633
abnormal embryo size 2 | 112
decreased fasted circulating g... 2 | 49
decreased mean corpuscular vol... 2 | 50
hypoactivity 2 | 89
abnormal behavior 1 | 226
abnormal embryo turning 1 | 15
abnormal hindbrain development 1 | 24
abnormal kidney morphology 1 | 30
abnormal midbrain development 1 | 22
abnormal neural tube closure 1 | 37
abnormal seminal vesicle morph... 1 | 47
abnormal spine curvature 1 | 7
abnormal vertebrae morphology 1 | 14
cardiovascular system phenotyp... 1 | 35
decreased caudal vertebrae num... 1 | 49
decreased circulating HDL chol... 1 | 77
decreased circulating LDL chol... 1 | 37
decreased circulating alanine ... 1 | 53
decreased circulating alkaline... 1 | 41
decreased circulating choleste... 1 | 85
decreased circulating potassiu... 1 | 17
decreased erythrocyte cell num... 1 | 43
decreased hemoglobin content 1 | 53
decreased mean corpuscular hem... 1 | 34
decreased mean corpuscular hem... 1 | 19
decreased mean platelet volume 1 | 12
decreased memory-marker CD4-po... 1 | 4
decreased prepulse inhibition 1 | 52
decreased total body fat amoun... 1 | 186
enlarged spleen 1 | 26
hyperactivity 1 | 108
increased body weight 1 | 42
increased circulating alkaline... 1 | 119
increased hematocrit 1 | 36
increased mean corpuscular hem... 1 | 93
increased or absent threshold ... 1 | 128
short tibia 1 | 82
small adrenal glands 1 | 15
small lymph nodes 1 | 1
thrombocytosis 1 | 23

Disease

ovarian cancer 28 | 8,484
glioblastoma 21 | 5,572
atypical teratoid / rhabdoid tumor 18 | 4,369
medulloblastoma, large-cell 18 | 6,234
osteosarcoma 18 | 7,933
oligodendroglioma 15 | 2,849
ependymoma 14 | 2,514
lung cancer 13 | 4,466
psoriasis 13 | 6,685
astrocytic glioma 12 | 2,241
pilocytic astrocytoma 12 | 3,086
Pick disease 11 | 1,893
adult high grade glioma 11 | 2,148
diabetes mellitus 11 | 1,663
lung carcinoma 11 | 2,844
Breast cancer 10 | 3,094
Alzheimer's disease 9 | 644
Parkinson's disease 9 | 364
Multiple myeloma 8 | 1,327
medulloblastoma 8 | 1,524
primitive neuroectodermal tumor 8 | 3,031
Cancer 7 | 2,346
Neurodegenerative disease 7 | 383
intraductal papillary-mucinous carcinoma (IPMC) 7 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 7 | 3,289
invasive ductal carcinoma 7 | 2,950
pediatric high grade glioma 7 | 2,712
astrocytoma 6 | 1,493
intraductal papillary-mucinous adenoma (IPMA) 6 | 2,956
pancreatic cancer 6 | 2,300
sonic hedgehog group medulloblastoma 6 | 1,482
tuberculosis 6 | 1,557
Dementia 5 | 129
Waldenstrons macroglobulinemia 5 | 765
dermatomyositis 5 | 933
group 3 medulloblastoma 5 | 2,254
non-small cell lung cancer 5 | 2,798
acute myeloid leukemia 4 | 780
acute quadriplegic myopathy 4 | 1,157
colon cancer 4 | 1,475
cystic fibrosis 4 | 1,665
group 4 medulloblastoma 4 | 1,875
lung adenocarcinoma 4 | 2,713
pancreatic ductal adenocarcinoma liver metastasis 4 | 1,795
pituitary cancer 4 | 1,972
posterior fossa group B ependymoma 4 | 1,530
primary pancreatic ductal adenocarcinoma 4 | 1,271
subependymal giant cell astrocytoma 4 | 2,287
Amyotrophic Lateral Sclerosis 3 | 431
Atopic dermatitis 3 | 944
Brain disease 3 | 83
Carcinoma 3 | 2,147
Cutis laxa 3 | 28
Heart disease 3 | 279
Kidney disease 3 | 396
Osteopetrosis 3 | 40
Osteoporosis 3 | 257
Parkinson Disease 3 | 102
Stomach Neoplasms 3 | 282
Toxic encephalopathy 3 | 131
breast carcinoma 3 | 1,614
hepatocellular carcinoma 3 | 532
malignant mesothelioma 3 | 3,162
posterior fossa group A ependymoma 3 | 1,511
sarcoidosis 3 | 358
spina bifida 3 | 1,064
tuberculosis and treatment for 6 months 3 | 686
Arthritis 2 | 248
Asthma 2 | 349
Coloboma 2 | 51
Degenerative polyarthritis 2 | 93
Diabetes Mellitus, Non-Insulin-Dependent 2 | 157
Down syndrome 2 | 548
Esophageal Neoplasms 2 | 67
Eye disease 2 | 55
Gaucher disease type 1 2 | 171
Hyperglycemia 2 | 120
Hypertension 2 | 287
Liver carcinoma 2 | 217
Lung disease 2 | 132
Nerve Degeneration 2 | 73
Neuropathy 2 | 210
Obesity 2 | 616
PARKINSON DISEASE, LATE-ONSET 2 | 18
Peripheral Neuropathy 2 | 303
Reperfusion Injury 2 | 84
Skin disease 2 | 65
Vascular disease 2 | 281
atypical teratoid/rhabdoid tumor 2 | 1,095
glioblastoma multiforme 2 | 347
interstitial cystitis 2 | 2,299
juvenile dermatomyositis 2 | 1,189
non-small cell lung carcinoma 2 | 413
pancreatic carcinoma 2 | 567
primary Sjogren syndrome 2 | 789
Diabetes Mellitus, Experimental 1 | 106
Frontotemporal dementia 1 | 41
Neuronal Ceroid-Lipofuscinoses 1 | 4
Neuronal ceroid lipofuscinosis 1 | 28
Stevens-Johnson syndrome 1 | 78

Tissue

Blood and immune system 44 | 17,995
Cardiovascular System 44 | 17,958
Digestive Tract 44 | 18,473
Endocrine System 44 | 18,512
Female tissues 44 | 18,647
Liver and Pancreas 44 | 18,136
Male tissues 44 | 17,969
Nervous System 44 | 18,561
Respiratory system 44 | 17,484
Skin and soft tissues 44 | 18,115
Urinary Tract 44 | 18,444

Target Family

Enzyme 25 | 4,146
Non-IDG 14 | 11,971
Kinase 4 | 634
Transporter 1 | 473

GO Process

regulation of macroautophagy 44 | 44
transcription, DNA-templated 1,779 | 1,779
regulation of transcription, D... 1,170 | 1,170
signal transduction 969 | 969
positive regulation of transcr... 845 | 845
G-protein coupled receptor sig... 666 | 666
negative regulation of transcr... 620 | 620
apoptotic process 506 | 506
positive regulation of transcr... 504 | 504
negative regulation of transcr... 483 | 483
multicellular organism develop... 456 | 456
positive regulation of cell pr... 451 | 451
cell differentiation 442 | 442
negative regulation of apoptot... 440 | 440
innate immune response 410 | 410
cell adhesion 409 | 409
immune response 398 | 398
negative regulation of cell pr... 379 | 379
inflammatory response 371 | 371
viral process 368 | 368
spermatogenesis 365 | 365
cell proliferation 358 | 358
protein transport 356 | 356
intracellular signal transduct... 355 | 355
cell division 330 | 330
regulation of transcription fr... 324 | 324
protein phosphorylation 320 | 320
response to drug 297 | 297
positive regulation of apoptot... 292 | 292
nervous system development 275 | 275
transcription from RNA polymer... 272 | 272
cell surface receptor signalin... 267 | 267
protein ubiquitination 260 | 260
transport 257 | 257
cell-cell signaling 249 | 249
regulation of immune response 247 | 247
positive regulation of gene ex... 242 | 242
mitotic nuclear division 241 | 241
MAPK cascade 238 | 238
chemical synaptic transmission 238 | 238
mRNA splicing, via spliceosome 219 | 219
angiogenesis 218 | 218
small GTPase mediated signal t... 215 | 215
translation 215 | 215
rRNA processing 209 | 209
intracellular protein transpor... 205 | 205
cellular response to DNA damag... 201 | 201
cell cycle 200 | 200
proteasome-mediated ubiquitin-... 200 | 200
proteolysis 199 | 199
visual perception 198 | 198
DNA repair 196 | 196
extracellular matrix organizat... 193 | 193
regulation of apoptotic proces... 190 | 190
brain development 183 | 183
positive regulation of cell mi... 181 | 181
protein polyubiquitination 181 | 181
in utero embryonic development 178 | 178
Fc-epsilon receptor signaling ... 176 | 176
Wnt signaling pathway 175 | 175
ion transmembrane transport 174 | 174
protein homooligomerization 173 | 173
heart development 170 | 170
positive regulation of ERK1 an... 170 | 170
blood coagulation 169 | 169
cell migration 168 | 168
regulation of cell proliferati... 167 | 167
protein autophosphorylation 166 | 166
response to hypoxia 164 | 164
mRNA processing 162 | 162
negative regulation of canonic... 162 | 162
protein folding 162 | 162
T cell receptor signaling path... 161 | 161
response to lipopolysaccharide 161 | 161
defense response to virus 160 | 160
RNA splicing 158 | 158
aging 158 | 158
positive regulation of I-kappa... 158 | 158
axon guidance 157 | 157
homophilic cell adhesion via p... 155 | 155
sensory perception of smell 155 | 155
ER to Golgi vesicle-mediated t... 151 | 151
interferon-gamma-mediated sign... 150 | 150
protein ubiquitination involve... 150 | 150
transcription initiation from ... 150 | 150
ubiquitin-dependent protein ca... 149 | 149
DNA replication 144 | 144
adaptive immune response 139 | 139
cell cycle arrest 139 | 139
receptor-mediated endocytosis 139 | 139
skeletal system development 136 | 136
regulation of cell shape 135 | 135
regulation of small GTPase med... 134 | 134
G2/M transition of mitotic cel... 133 | 133
oxidation-reduction process 133 | 133
positive regulation of cytosol... 133 | 133
protein stabilization 133 | 133
sensory perception of sound 132 | 132
positive regulation of NF-kapp... 131 | 131
antigen processing and present... 130 | 130
type I interferon signaling pa... 130 | 130

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
V-type proton ATPase catalytic subunit A ATP6V1A Tbio Enzyme -1.80191 64.7 120
Exocyst complex component 7 EXOC7 Tbio Non-IDG -1.72231 55.8 158
V-type proton ATPase 116 kDa subunit a isoform 1 ATP6V0A1 Tbio Enzyme -1.36455 23.7 59
Exocyst complex component 8 EXOC8 Tbio Non-IDG -1.17455 14.6 65
V-type proton ATPase subunit e 2 ATP6V0E2 Tdark Enzyme 0.18 0.40 19
V-type proton ATPase subunit E 1 ATP6V1E1 Tbio Enzyme -0.98803 10.3 111
Cyclin-dependent-like kinase 5 CDK5 Tchem Kinase -3.02975 1184.8 589
Sorting nexin-32 SNX32 Tdark Non-IDG 1.08 0.07 75
Vacuolar protein sorting-associated protein 35 VPS35 Tchem Non-IDG -1.95928 98.3 116
Calpain small subunit 1 CAPNS1 Tbio Non-IDG -2.85177 736.0 131